Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
François Corbin, Pierre Douville & Marcel Lebel. (2011) Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism. International Journal of Nephrology and Renovascular Disease 4, pages 115-120.
Read now
Read now
Christina Westerdahl, Anders Bergenfelz, Anders Isaksson, Christina Nerbrand & Stig Valdemarsson. (2011) Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area. Scandinavian Journal of Primary Health Care 29:1, pages 57-62.
Read now
Read now
Christina Westerdahl, Anders Bergenfelz, Johanna Larsson, Christina Nerbrand, Stig Valdemarsson, Anders Wihl & Anders Isaksson. (2009) Re‐evaluation of the fludrocortisone test: duration, NaCl supplementation and cut‐off limits for aldosterone. Scandinavian Journal of Clinical and Laboratory Investigation 69:2, pages 234-241.
Read now
Read now
Articles from other publishers (18)
Renata Libianto, Michael Stowasser, Grant Russell, Peter J Fuller & Jun Yang. (2023) Improving Detection Rates for Primary Aldosteronism. Experimental and Clinical Endocrinology & Diabetes 131:07/08, pages 402-408.
Crossref
Crossref
Joshua Ariens, Andrea R. Horvath, Jun Yang & Kay Weng Choy. (2022) Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care. Endocrine 77:1, pages 11-20.
Crossref
Crossref
Renata Libianto, Grant M Russell, Michael Stowasser, Stella M Gwini, Peta Nuttall, Jimmy Shen, Morag J Young, Peter J Fuller & Jun Yang. (2022) Detecting primary aldosteronism in Australian primary care: a prospective study. Medical Journal of Australia 216:8, pages 408-412.
Crossref
Crossref
Renata Libianto, Peter J. Fuller, Morag J. Young & Jun Yang. (2020) Primary aldosteronism is a public health issue: challenges and opportunities. Journal of Human Hypertension 34:7, pages 478-486.
Crossref
Crossref
Yuhong Yang, Martin Reincke & Tracy Ann Williams. (2020) Prevalence, diagnosis and outcomes of treatment for primary aldosteronism. Best Practice & Research Clinical Endocrinology & Metabolism 34:2, pages 101365.
Crossref
Crossref
Fredrik Sellgren, Anna Koman, Erik Nordenström, Per Hellman, Joakim Hennings & Andreas Muth. (2019) Outcomes After Surgery for Unilateral Dominant Primary Aldosteronism in Sweden. World Journal of Surgery 44:2, pages 561-569.
Crossref
Crossref
Sabine C Käyser, Jaap Deinum, Wim JC de Grauw, Bianca WM Schalk, Hans JHJ Bor, Jacques WM Lenders, Tjard R Schermer & Marion CJ Biermans. (2018) Prevalence of primary aldosteronism in primary care: a cross-sectional study. British Journal of General Practice 68:667, pages e114-e122.
Crossref
Crossref
Sandi-Jo Galati, Khadeen C. Cheesman, Ryan Springer-Miller, Sarah M. Hopkins, Lawrence Krakoff, Emilia Bagiella, Rachel A. Zhuk, Tiffany K. Ying, Chelsey Amer, Michael K. Boyajian, W.B. InabnetIIIIII & Alice C. Levine. (2016) Prevelence of Primary Aldosteronism in an Urban Hypertensive Population. Endocrine Practice 22:11, pages 1296-1302.
Crossref
Crossref
Paula O’Shea, Jennifer J Brady, Noelle Gallagher, Michael C Dennedy & Maria Fitzgibbon. (2015) Establishment of reference intervals for aldosterone and renin in a Caucasian population using the newly developed Immunodiagnostic Systems specialty immunoassay automated system. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 53:3, pages 390-398.
Crossref
Crossref
Gregory A. Kline. (2015) Primary Aldosteronism: unnecessary complexity in definition and diagnosis as a barrier to wider clinical care. Clinical Endocrinology 82:6, pages 779-784.
Crossref
Crossref
Pieter M. Jansen, Bert-Jan H. van den Born, Wijnanda J. Frenkel, Emile L.E. de Bruijne, Jaap Deinum, Michiel N. Kerstens, Yvo M. Smulders, Arend Jan Woittiez, Johanna A.M. Wijbenga, Robert Zietse, A.H. Jan Danser & Anton H. van den Meiracker. (2014) Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism. Journal of Hypertension 32:1, pages 115-126.
Crossref
Crossref
Cristina Volpe, Hans Wahrenberg, Bertil Hamberger & Marja Thorén. (2012) Screening for primary aldosteronism in a primary care unit. Journal of the Renin-Angiotensin-Aldosterone System 14:3, pages 212-219.
Crossref
Crossref
A. Hannemann, M. Bidlingmaier, N. Friedrich, J. Manolopoulou, A. Spyroglou, H. Volzke, F. Beuschlein, J. Seissler, R. Rettig, S. B. Felix, R. Biffar, A. Doring, C. Meisinger, A. Peters, H. E. Wichmann, M. Nauck, H. Wallaschofski & M. Reincke. (2012) Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. European Journal of Endocrinology 167:1, pages 7-15.
Crossref
Crossref
Michiel N Kerstens, Anneke C Muller Kobold, Marcel Volmer, Jan Koerts, Wim J Sluiter & Robin PF Dullaart. (2011) Reference Values for Aldosterone–Renin Ratios in Normotensive Individuals and Effect of Changes in Dietary Sodium Consumption. Clinical Chemistry 57:11, pages 1607-1611.
Crossref
Crossref
Christina WesterdahlAnders Bergenfelz, Anders Isaksson & Stig Valdemarsson. (2011) Captopril suppression: limitations for confirmation of primary aldosteronism. Journal of the Renin-Angiotensin-Aldosterone System 12:3, pages 326-332.
Crossref
Crossref
J.J. MukherjeeC.M. Khoo, A.C. Thai, S.B. Chionh, Lim Pin & K.O. Lee. (2009) Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism. Diabetes and Vascular Disease Research 7:1, pages 6-13.
Crossref
Crossref
Joachim P. Sturmberg, Eu‐gene Siew, Leonid Churilov & Kate Smith‐Miles. (2009) Identifying patterns in primary care consultations: a cluster analysis. Journal of Evaluation in Clinical Practice 15:3, pages 558-564.
Crossref
Crossref
Pieter M Jansen, AH Jan Danser, Ben P Imholz & Anton H van den Meiracker. (2009) Aldosterone-receptor antagonism in hypertension. Journal of Hypertension 27:4, pages 680-691.
Crossref
Crossref